Lin Yiming, Lin Chunmei, Lin Weihua, Zheng Zhenzhu, Han Mingya, Fu Qingliu
Neonatal Disease Screening Center of Quanzhou, Quanzhou Maternal and Children's Hospital, 700 Fengze Street, Quanzhou, 362000, Fujian Province, China.
Genuine Diagnostics Company Limited, 859 Shixiang West Road, Hangzhou, 310007, Zhejiang Province, China.
BMC Med Genet. 2018 Jul 11;19(1):114. doi: 10.1186/s12881-018-0635-4.
Methylmalonic acidemia (MMA) is an autosomal recessive inherited disorder caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (mut0 enzymatic subtype or mut- enzymatic subtype, respectively); a defect in the transport or synthesis of its cofactor, adenosyl-cobalamin (cblA, cblB, or cblD-MMA); or deficiency of the enzyme methylmalonyl-CoA epimerase. The cblA type of MMA is very rare in China. This study aimed to describe the biochemical, clinical, and genetic characteristics of two siblings in a Chinese family, suspected of having the cblA-type of MMA.
The Chinese family of Han ethnicity of two siblings with the cblA-type of MMA, was enrolled. Target-exome sequencing was performed for a panel of MMA-related genes to detect causative mutations. The influence of an identified missense variant on the protein's structure and function was analysed using SIFT, PolyPhen-2, PROVEAN, and MutationTaster software. Moreover, homology modelling of the human wild-type and mutant proteins was performed using SWISSMODEL to evaluate the variant.
The proband was identified via newborn screening (NBS); whereas, her elder brother, who had not undergone expanded NBS, was diagnosed later through genetic family screening. The younger sibling exhibited abnormal biochemical manifestations, and the clinical performance was relatively good after treatment, while the older brother had a mild biochemical and clinical phenotype, mainly featuring poor academic performance. A novel, homozygous missense c.365T>C variant in exon 2 of their MMAA genes was identified using next-generation sequencing and validated by Sanger sequencing. Several different types of bioinformatics software predicted that the novel variant c.365T>C (p.L122P) was deleterious. Furthermore, three-dimensional crystal structure analysis revealed that replacement of Leu122 with Pro122 led to the loss of two intramolecular hydrogen bonds between the residue at position 122 and Leu188 and Ala119, resulting in instability of the MMAA protein structure.
The two siblings suspected of having the cblA-type of MMA showed mild phenotypes during follow-up, and a novel, homozygous missense variant in their MMAA genes was identified. We believe that the clinical features of the two siblings were associated with the MMAA c.365T>C variant; however, further functional studies are warranted to confirm the variant's pathogenicity.
甲基丙二酸血症(MMA)是一种常染色体隐性遗传疾病,由甲基丙二酰辅酶A变位酶完全或部分缺乏(分别为mut0酶亚型或mut-酶亚型)、其辅因子腺苷钴胺素的转运或合成缺陷(cblA、cblB或cblD-MMA)或甲基丙二酰辅酶A差向异构酶缺乏引起。在中国,cblA类型的MMA非常罕见。本研究旨在描述一个疑似患有cblA类型MMA的中国家庭中两名兄弟姐妹的生化、临床和遗传特征。
招募了一个患有cblA类型MMA的两名汉族兄弟姐妹的中国家庭。对一组与MMA相关的基因进行目标外显子测序,以检测致病突变。使用SIFT、PolyPhen-2、PROVEAN和MutationTaster软件分析已鉴定的错义变体对蛋白质结构和功能的影响。此外,使用SWISSMODEL对人类野生型和突变型蛋白质进行同源建模,以评估该变体。
先证者通过新生儿筛查(NBS)确诊;而她未接受扩大NBS的哥哥,后来通过基因家族筛查被诊断出来。年幼的兄弟姐妹表现出异常的生化表现,治疗后临床表现相对良好,而哥哥的生化和临床表型较轻,主要表现为学习成绩差。使用下一代测序在他们的MMAA基因外显子2中鉴定出一个新的纯合错义c.365T>C变体,并通过桑格测序进行了验证。几种不同类型的生物信息学软件预测,新变体c.365T>C(p.L122P)是有害的。此外,三维晶体结构分析表明,用Pro122取代Leu122导致122位残基与Leu188和Ala119之间的两个分子内氢键丢失,导致MMAA蛋白质结构不稳定。
两名疑似患有cblA类型MMA的兄弟姐妹在随访期间表现出轻度表型,并在他们的MMAA基因中鉴定出一个新的纯合错义变体。我们认为这两名兄弟姐妹的临床特征与MMAA c.365T>C变体有关;然而,需要进一步的功能研究来证实该变体的致病性。